ACI calls potential FDA changes a “risk”

doctor with medical gloves

WASHINGTON, DC — The American Cleaning Institute (ACI) is warning against the FDA’s impending regulations on antibacterial healthcare hygiene products slated for proposal in 2015, according to a press release.

ACI says previous public announcements made by FDA questioning the safety and efficacy of key antibacterial ingredients have failed to acknowledge the full database of studies and research supporting the ingredients’ benefits and safety profiles.

The FDA Nonprescription Drugs Advisory Committee (NDAC) recently heard a presentation from ACI, including healthcare professionals and industry safety experts, in which it defended the use of the active ingredients used in antibacterial products.

“Any effort by FDA that would impede availability of these important ingredients would put patients and healthcare personnel at risk,” said Dr. Paul DeLeo, ACI Associate Vice President of Environmental Safety. “These products clearly save lives by reducing bacterial transmission, which can cause infections in healthcare settings. By reducing healthcare-associated infections, these products also reduce healthcare costs.”

Cleanfax Staff

Cleanfax provides cleaning and restoration professionals with information designed to help them manage and grow their businesses. https://cleanfax.com/

Follow Cleanfax Staff

Related Posts

Share This Article

Join Our Newsletter

Expert Videos

Related Content

John Nothdurft at the ISSA Show North America 2026

Advocacy Must Move as Fast as the Political Landscape

Fall 2026 Cleanfax

What You Might Have Missed in Our Fall 2026 Issue

ISSA Show North America

ISSA Show North America 2026 Starts Today

EPA

EPA Demos New Lead Identification Tech

Atmospheric River West Coast December 2025

5 Years After British Columbia’s Devastating Atmospheric River, Preparedness Still Trails

Polls